Boston, San Francisco, Stockholm – January 12, 2023
HASSELT, BELGIUM | BEVERLY, MA – September 20, 2022
HASSELT, BELGIUM | BOSTON, MA – September 15, 2022
HASSELT, BELGIUM | BOSTON, MA – September 6, 2022
Hasselt, Belgium | Boston, MA, USA | Aug. 4, 2022
Lisbon, Portugal | Hasselt, Belgium | Boston, MA, USA | April 25th, 2022
Copenhagen, Denmark | Hasselt, Belgium | Boston, MA, USA | Basel/Rotkreuz, Switzerland | March 24th, 2021
Zürich, Switzerland | Hasselt, Belgium | Boston, MA, USA | February 4th, 2021 | We're excited to announce a collaboration between Tecan and UgenTec to...
Toronto, Canada | Hasselt, Belgium | Boston, MA, USA | December 17th, 2020 | UgenTec and DMark Biosciences today announced a distributor agreement to ...
Hasselt, Belgium | Boston, MA, USA | Veenendaal, The Netherlands | November 10th, 2020 | UgenTec and MolGen today announced a collaboration bringing a...
Paris, France | Brussels, Belgium | August 27, 2020 | The centralized hospital procurement group UniHA and UgenTec have agreed on a FastFinder PCR sof...
Brussels, Belgium | August 3, 2020 | The Belgian government and UgenTec have agreed to extend their existing agreement to automate COVID PCR analysis ...
Freiburg, Germany | Boston, MA | Today, Eurofins GeneScan Technologies GmbH and UgenTec, Inc. announce the successful NF VALIDATION certification of f...
Today, Eurofins GeneScan Technologies GmbH and UgenTec announced a collaboration on the development of assay plugins for Eurofins GeneScan Technologie...
UgenTec, an innovative software provider for molecular diagnostics, today announced it won a $550,000 (€490,000) grant from the Flemish government (VL...
Sentinel Diagnostics today announced its new end-to-end platform for molecular diagnostics, dubbed SENTiNAT®200. The platform will support the full ra...
HASSELT, BELGIUM & BOSTON, MA, US – 28/09/18 |UgenTec today announced a new end-point PCR analysis software called FastFinder Genotyper. FastFinder G...
Hasselt, Belgium & Boston, Massachusetts - UgenTec, a software company focusing on simplifying and automating real-time qPCR diagnostics, today announ...
We're excited to announce today our partnership with Serosep Ltd., a leading global manufacturer of molecular solutions for clinical laboratories. In ...
We're excited to announce our brand new initiative in molecular diagnostics: the Molecular Automation Network. This network is a consortium of compani...
We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 milli...
HERSTAL & HASSELT, BELGIUM – 23/01/18 | UgenTec, an innovative European medical device software company that develops artificially intelligent PCR int...
Hasselt, Belgium, December 19, 2017. | Steven Verhoeven, previously Agilent’s head of genomics software, will join UgenTec to take up the role of chie...
LUXEMBOURG, LUXEMBOURG & HASSELT, BELGIUM – 05/12/17 | Fast Track Diagnostics S.à.r.l., one of the leading global suppliers of syndromic real-time PCR...
DARMSTADT, GERMANY and HASSELT, BELGIUM, September 21st, 2017 – R-Biopharm AG announced today it has entered into an agreement with UgenTec to collabo...
With FastFinder 3.0, we've taken another step towards full PCR automation. In this blogpost, you'll find a list of the most important features and cha...
BRUSSELS, BELGIUM and HASSELT, BELGIUM—. UgenTec, the Belgian PCR automation software company is approved for the SME Instrument Phase 1 by the Europe...
UgenTec, the Belgian PCR automation software company and Hamann Laborautomation today announced their partnership venture into the PCR middleware land...
Founded in 2009 in Sydney, SpeeDx’ current IVD portfolio consists of two multiplex assays: ResistancePlus™ MG and PlexPCR™HSV-1&2, VZV. The company i...
UgenTec & PathoFinder have successfully rolled out the interpretation solution for PathoFinder’s next generation multiplex PCR 2SMART assays.
UgenTec NV, the European bio-informatics company that develops artificially intelligent PCR interpretation software, and SpeeDx Pty. Ltd., a developer...
UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €2.1...
UgenTec has been nominated for the 2016 Rising Star award, together with nine other innovative and rapid growing companies. The Rising Star selection ...
Today, we can announce that our team has successfully passed the audit for the ISO 13485:2012 Medical Devices. You can check our official certificatio...
We're happy to announce that Unizo, the organization that represents employers and entrepreneurs in Flanders, has elected UgenTec to be the "Most Prom...
We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 000 i...
We are proud to announce that we've won the “Flanders Future” award. The award is handed to companies that are deemed the most capable of achieving in...
UgenTec’s FastFinder has won the “Healthcare idea award 2014” for the most innovative product in healthcare. The software, developed by UgenTec, allow...
